# Asgard Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/asgard-therapeutics

- Industry: Biotechnology
- Headquarters: Lund, Sweden
- Website: www.asgardthx.com
- Total disclosed funding: $39M
- Latest round: Series A (Mar 14, 2024)
- Investors on record: 5

## About

Founded in 2018 and based in Lund, Sweden, Asgard Therapeutics, a spin-off from Lund University, is a biotechnology company that develops cancer immunotherapies based on cell fate reprogramming. In March 2024, Asgard Therapeutics AB raised EUR 30 million in series A funding co-led by investors RV Invest GmbH and Johnson & Johnson Innovation, with participation from other investors Novo Holdings, Boehringer Ingelheim Venture, and Industrifonden. The firm as of July 2024, is led by its co-founders, Cristiana Pires (CEO), Fábio Rosa (Head of Research), and Filipe Pereira (Head of Innovation).

Asgard Therapeutics' lead program, AT-108, leverages its TrojanDC concept to create off-the-shelf gene therapies that convert cancer cells into antigen-presenting cells, thus facilitating immune responses against tumors. The company's approach addresses common challenges in traditional cell-based therapies, such as logistics and manufacturing. Additionally, its platform enhances scalability and efficiency in immunotherapy.

The company plans to utilize the March 2024 funding to support the development of its technology and for team expansion.

## Funding rounds

- Series A, Mar 14, 2024, $33M — Johnson & Johnson Innovation, Novo Holdings, Industrifonden, Boehringer Ingelheim Venture, RV Invest
- Seed, Nov 9, 2021, $6M — Novo Holdings, Industrifonden, Boehringer Ingelheim Venture

## Investors

- Novo Holdings — Seed, Series A
- Industrifonden (https://capitalatlas.ai/funds/industrifonden) — Seed, Series A
- Boehringer Ingelheim Venture (https://capitalatlas.ai/funds/boehringer-ingelheim-venture) — Seed, Series A
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series A
- RV Invest (https://capitalatlas.ai/funds/rv-invest) — Series A